BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Cytognos, S.L. - ECPv4.9.7//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Cytognos, S.L.
X-ORIGINAL-URL:https://www.cytognos.com
X-WR-CALDESC:Events for Cytognos, S.L.
BEGIN:VTIMEZONE
TZID:"Europe/Paris"
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20200329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20201025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID="Europe/Paris":20200929T110000
DTEND;TZID="Europe/Paris":20200929T120000
DTSTAMP:20260425T185909
CREATED:20200922T080810Z
LAST-MODIFIED:20200929T152051Z
UID:13049-1601377200-1601380800@www.cytognos.com
SUMMARY:Webinar - Update on Flow Cytometry: Leukaemia and Immunotherapy (2020/09/29) - 11:00 AM CEST
DESCRIPTION:Join this webinar with our guest Jordi Petriz\, PhD \n“Update on Flow Cytometry: Leukaemia and Immunotherapy” \nTechnology advances provide new and improved tools for clinical evaluation which will eventually have a positive impact on patient care. High-quality and accurate results are essential for clinicians to keep up-to-date with the latest flow cytometry technology. \nFunctional Cytomics allow for the discovery and characterization of new cell subpopulations\, mechanisms of resistance to immunotherapy and chemotherapy; and multiplexed evaluations for detecting malignant clones at a single-cell level. \nImmune-phenotyping and functional analysis can bring to light complex cellular mechanisms and\, thereby\, help to unravel the biology of leukemogenesis as well as impulse clinical implementation of novel therapies. \nIn this webinar Jordi Petriz will discuss state-of-the-art flow technology and its impact on Immunotherapy and Leukaemia evaluations. \n\nJordi Petriz received his BSc degree in Biochemistry and Animal Biology from the University of Barcelona.\nIn 1998 he obtained his PhD degree in Physiology and Immunology specializing in functional-based mechanisms on multidrug resistance against anticancer agents.\nAs a postdoctoral fellow he applied new cytomic approaches to address questions on whole blood counting of CD34+ progenitor cells.\nSince 2000\, he joined the Subcommittee on Quality Assessment of Hematopoietic Stem Cell Grafts. Since then he has become a Principal Investigator at the IJC.\nJordi Petriz has authored or co-authored nearly 100 research contributions; some in high impact Journals including Nature Medicine and Leukemia. His current work focuses on linking stemness with ABC transporters. He is studying several genes involved in different aspects of stem cell activation\, including some that encode for multidrug resistance transporters\, and others that regulate self-renewal and differentiation.\nHe has been the President of the Iberian Society for Cytometry (SIC)\, Councilor at the European Society for Clinical Cell Analysis (ESCCA) Executive Board\, and current Corse Committee Member at the Clinical Cytometry Education Network (CCEN). He finally joined the IJC at the beginning of 2015.\n\n
URL:https://www.cytognos.com/event/webinar-update-on-flow-cytometry-leukaemia-and-immunotherapy-2020-09-29-1100-am-cest/
CATEGORIES:Webinars
ATTACH;FMTTYPE=image/png:https://www.cytognos.com/wp-content/uploads/newsletter-jordi-petriz-min.png
END:VEVENT
END:VCALENDAR